Connection

Michael Hallek to Leukemia, Prolymphocytic, T-Cell

Back to Details
This is a "connection" page, showing publications Michael Hallek has written about Leukemia, Prolymphocytic, T-Cell.
Michael Hallek
Connection Strength
0.383
Leukemia, Prolymphocytic, T-Cell
  1. New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance. Leuk Lymphoma. 2019 03; 60(3):649-657.
    View in: PubMed
    Score: 0.196
  2. Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL. Nat Commun. 2018 02 15; 9(1):697.
    View in: PubMed
    Score: 0.188
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.